NCT02329496 - REPRISE Next Generation Delivery System | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 3, 2014

Primary Completion Date

October 6, 2016

Study Completion Date

October 19, 2017

Conditions

Aortic Stenosis

Interventions

DEVICE

Lotus Valve and LOTUS Edge Valve System

Transcatheter aortic valve replacement (TAVR) with the Lotus Valve System with the Next Generation Delivery System and LOTUS Edge Valve System, with either the Lotus Introducer or iSleeve Introducer Sets

Trial Locations (2)

3168

Monash Heart, Clayton

4032

Prince Charles Hospital, Chermside